Novartis India Q4 net up at Rs23.90 crore
Mumbai: Novartis India has posted a net profit of Rs 23.87 crore for the quarter ended March 2007 as against Rs19.99 crore in the corresponding quarter in 2006.

Total revenue for the quarter has increased to Rs144.64 crore against Rs121.52 crore shown in the same period previous year.

For the year ended March 2007, the company made a net profit of Rs88.55 crore against Rs 107.89 crore during 2006. Total revenue for the year has risen marginally to Rs592.32 crore as compared to Rs591.93 crore in 2006.
Back to News Review index page  

UTV Group to launch eight new channels by March 2008
Dubai: UTV Group is planning to roll-out eight new channels by March 2008 with half the channels targeted at young urban viewers. The channel will invest $200 million in the new channels launch. Four of the channels will go on air from August 15 this year and the rest by March 2008.

The company is also going global and is tying up with major Hollywood production houses. It would produce at least 12 movies a year, including one international title, possibly in collaboration with players in Hollywood or other places.

UTV has a market capitalisation of $220 million and is listing its motion picture arm on London's Alternative Investment Market next month.
Back to News Review index page  

Strides Arcolab opens facility in Brazil
Mumbai: Pharmaceuticals major Strides Arcolab has opened its sterile injectable facility at Compos in Rio de Janeiro, Brazil.

The facility was built at a cost of $30 million, and would become a global site for the Strides group's growing sterile business, according to the company.

The sterile injectable facility at Brazil is for Penems and Penicillins. Strides Arcolab said the Brazilian operations would continue to play a significant role in the Strides growth strategy.

Earlier in February the UK-based Medicines and Healthcare Products Regulatory Agency (MHRA) rated the company's sterile products and antibiotics plant complex in Bangalore as compliant with the principles and guidelines of good manufacturing practices.
Back to News Review index page  

German firm Klockner to open facility in India: to make India R&D hub
New Delhi: German company Klockner Pentaplast (KP), which makes packaging material, is planning to set up a pharmaceutical films manufacturing facility in Aurangabad, Maharashtra with an investment of of Rs 83.25 crore.

The greenfield facility would have a capacity of 15,000 tonne per annum, and would begin operations by the first quarter of 2008.

The company is also planning to make India a hub for its pharma packaging research in Asia.

The company said India is a key market in Asia with major pharmaceutical companies here being its customers. It plans to invest $20 million in a new pharmaceutical film making facility here, which would cater to both the domestic and the export market.

The company would make India a hub for pharmaceutical packaging solutions in Asia, and anticipates revenues of $30 million in the first year of operations.

The company has been present in India since January 2006, and had closed the previous fiscal with revenues of $10 million.
Back to News Review index page